We aim to have near-term impact in the world by developing groundbreaking bioinspired technologies, ranging from novel devices and materials to high-value therapeutics and diagnostics, that are translated into commercial products and solutions. If you are interested in any of these technologies, please contact us.
MyoExo is a wearable, fabric-based device with integrated smart sensors that aims to accurately monitor the primary signs of Parkinson’s Disease over time, improving diagnosis and treatment.
Personalized cancer and infectious disease vaccine platform harnessing DNA nanotechnology to control the co-delivery and co-presentation of tumor antigen and adjuvant ligands to immune cells with nanoscale precision. This approach has potential to trigger enhanced immune responses against tumors and infectious pathogens.
Our eco-friendly air conditioning technology is a low-carbon-footprint evaporative cooling system that reduces indoor air temperature without adding humidity.
eLBP is a safe and cost-effective therapeutic for patients treated with beta-lactam antibiotics that safeguards against the loss of health-essential microbes while preventing the development and spread of antibiotic resistance.
SomaCode is solving the problem of cell therapy delivery by identifying unique molecular “zip codes” for disease and engineering cells to home to those zip codes, making cell therapies safer and more effective.
CircaVent is a novel drug discovery platform that combines predictive algorithms, high-throughput preclinical models, and human organoids to identify and test drugs that could treat mental health conditions like bipolar disorder.